There is no plan to develop FDCs with the sitagliptin 25 mg dose as use of this dose is quite low.

FORBES: FDA Approves Juvisync, Combination of Sitagliptin and Simvastatin

There is also no plan to develop FDCs with the simvastatin 5 mg dose as use of this dose is quite low as well.

FORBES: FDA Approves Juvisync, Combination of Sitagliptin and Simvastatin